We are live on ! Find out more
GI

GS Investments Portfolio holdings

AUM $175M
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+19.38%
3 Year Est. Return
+77.6%
5 Year Est. Return
+105.02%
10 Year Est. Return
AUM
$121M
AUM Growth
-$15.8M
Cap. Flow
-$1.11M
Cap. Flow %
-0.92%
Top 10 Hldgs %
37.88%
Holding
130
New
12
Increased
36
Reduced
44
Closed
15

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$1.3M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$1.15M
3
HSIC icon
Henry Schein
HSIC
+$1.06M
4
PRLB icon
Protolabs
PRLB
+$915K
5
TXN icon
Texas Instruments
TXN
+$872K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$2.09M
2
STZ icon
Constellation Brands
STZ
+$1.14M
3
UNH icon
UnitedHealth
UNH
+$1.06M
4
RVLV icon
Revolve Group
RVLV
+$636K
5
PYPL icon
PayPal
PYPL
+$509K

Sector Composition

Rank Sector Weight
1 Healthcare 17.06%
2 Technology 16.62%
3 Financials 14.19%
4 Industrials 12.39%
5 Consumer Discretionary 11.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLE icon
126
State Street Energy Select Sector SPDR ETF
XLE
$38.4B
-24
Closed -$710
BSCO
127
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
-2,557
Closed -$54.8K
CLDR
128
DELISTED
Cloudera, Inc.
CLDR
-326
Closed -$2.89K
ALXN
129
DELISTED
Alexion Pharmaceuticals
ALXN
-600
Closed -$58.8K
CELG
130
DELISTED
Celgene Corp
CELG
-21,060
Closed -$2.09M

Similar funds

GS Investments's Q4 2019 Portfolio in Review

As of Q4 2019, GS Investments held 130 positions worth $121M, down 12% from $137M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

GS Investments's Q4 2019 filing shows 12 new, 36 increased, 44 reduced and 15 closed positions. Its largest new stake was McKesson: 9,200 shares worth $1.23M. The largest sale was Celgene Corp, an estimated $2.09M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • GS Investments's largest Q4 2019 buy was McKesson: 9,200 shares worth $1.23M.
  • GS Investments added most to Henry Schein in Q4 2019, an estimated $1.06M increase.
  • GS Investments's biggest Q4 2019 reduction was UnitedHealth, cutting an estimated $1.06M.
  • GS Investments fully exited Celgene Corp in Q4 2019, selling an estimated $2.09M.
  • GS Investments's ten largest holdings make up 38% of its $121M portfolio in Q4 2019.
  • GS Investments opened 12 new positions and closed 15 in Q4 2019.
  • GS Investments's portfolio value fell 12% quarter-over-quarter to $121M.

Based on GS Investments's 13F filing for Q4 2019, filed 4 Feb 2020.